Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Epidemiology and surveillance of Gram-negative infections caused by carbapenemase-producing organisms (CPOs) in the UKRelease Date:Research Internal Medicine United Kingdom Advancing Care for Patients with Advanced ALK+ Non-Small Cell Lung Cancer (NSCLC)Education Oncology All Quality Improvement Solutions for the Diagnosis and Management of Migraine and Headache DisordersQuality Improvement Internal Medicine Canada, USA Shared Decision Making in Hemophilia Patient CareRelease Date:Quality Improvement Rare Disease China Real-World Atopic Dermatitis: Italian Insights GrantRelease Date:Research Inflammation & Immunology Italy Evolving Treatment Options in First-Line Metastatic Urothelial Carcinoma (mUC) and Muscle Invasive Bladder Cancer (MIBC)Education Oncology All Optimizing Care for patients with Muscle Invasive Bladder Cancer (MIBC)Release Date:Quality Improvement Oncology Canada Optimizing HRRm Testing and Workflow Integration in mCSPCRelease Date:Quality Improvement, Research Oncology Canada Driving Timely Biomarker Testing to Optimize Treatment Decisions for Colorectal Cancer Patients Across CanadaRelease Date:Partner: Colorectal Cancer Canada (CCC)Quality Improvement, Research Oncology Canada Antimicrobial Stewardship —Treatment optimization under antibiotics appropriate use policy in ChinaRelease Date:Research Inflammation & Immunology China Title Grant Type Focus Area Country Application Due Date Advances in Moderate-to-Severe Atopic Dermatitis for Dermatologists and AllergistsRelease Date:Education Inflammation & Immunology USA Quality Improvement in Pediatric Endocrinology fieldsRelease Date:Partner: The Japanese Society for Pediatric EndocrinologyQuality Improvement Rare Disease Japan Topical Hemostasis in Minimally Invasive SurgeryRelease Date:Education Hospital USA Advances in Immuno-Oncology Therapy in Urothelial CancerRelease Date:Education Oncology Japan Integration of Biomarker Testing into Treatment Planning for Metastatic Colorectal CancerQuality Improvement Oncology USA IBD Fellow Training in USRelease Date:Education Inflammation & Immunology USA Imaging Diagnostics for Differentiating Cardiac AmyloidosisRelease Date:Education Rare Disease Japan Improving Treatment Environment for Chronic Myeloid Leukemia (CML)Release Date:Education Oncology Japan Telemedicine Initiatives for Patients with Suspected Cardiomyopathy of Unknown CauseRelease Date:Education Rare Disease Japan Atrial Fibrillation and Venous Thromboembolism (excluding United States)Education Internal Medicine All Quantifying the Socio-Economic Burden of Disease for Dermatology Patients and CaregiversRelease Date:Research Inflammation & Immunology France, Germany, Italy, Japan, Spain, United Kingdom China Breast Cancer Landscape – Educational Needs AssessmentRelease Date:Education Oncology China